Closed · PAR-09-011 · CFDA 93.279 · Discretionary
Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24)
Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- April 8, 2010
- Close date
- -
- Expected awards
The verdict
Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24) is a closed discretionary listing from National Institutes of Health that offered Varies by applicant. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 12,419 other opportunities from National Institutes of Health.
- Varies
- award range
- Closed
- application status
- 93.279
- CFDA program
- 12,419
- other opportunities from National Institutes of Health
Archived opportunity record
Diversity-promoting Institutions Drug Abuse R… is closed (last close April 8, 2010). The parent program page for CFDA 93.279 is the reliable place to catch re-announcements. National Institutes of Health still indexes 12,419 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed April 8, 2010
Instrument
Grant
Description
-Purpose. This FOA issued by the National Institute on Drug Abuse (NIDA), National Institutes on Health, encourages Research Project Grant (R24) applications from institutions that historically and/or currently serve students from diverse and disadvantaged backgrounds that aim to increase their capacity to conduct drug abuse and addiction research. The applications should propose to foster the research career development of a diverse cadre of faculty, students and staff who are currently underrepresented in drug abuse research, and to enhance research infrastructure at the institution.-Mechanism of Support. This FOA utilizes the R24 mechanism. -Funds Available and Anticipated Number of Awards. Funding is available in the amount of up to $350,000 per year in direct costs. The number of awards supported will depend on the number and scientific merit of the proposals received.
Multi-door applicant board · 3 Grants.gov types
Grants.gov prints 3 distinct applicant types for Diversity-promoting Institutions Drug Abuse R… (Public / state-controlled institutions of higher education; Private institutions of higher education; Others (see official listing text)). Filter fit against the official announcement before drafting. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity codes span Education · Health (ED;HL). Only 256 other National Institutes of Health listings share this exact eligibility-code string (2% of 12,420).
- Code 06
- Public / state-controlled institutions of higher education
- Code 20
- Private institutions of higher education
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Parent Grant Program
Drug Abuse Research Programs
National Institutes of Health
Agency Contact
NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
More from National Institutes of Health
Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)
Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)
What to do next
Diversity-promoting Institutions Drug Abuse R… is closed; use the parent program and agency catalog for the next funding cycle.
- Parent CFDA 93.279 may publish future NOFOs under the same assistance listing. Open program
- Drug Abuse Research Programs indexes 170 Grants.gov listings in this extract. Program profile
- National Institutes of Health lists 12,419 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |